Viewing StudyNCT01767389



Ignite Creation Date: 2024-05-06 @ 1:15 AM
Last Modification Date: 2024-10-26 @ 11:01 AM
Study NCT ID: NCT01767389
Status: COMPLETED
Last Update Posted: 2014-08-04
First Post: 2013-01-04

Brief Title: Glucagon-like Peptide GLP Utilization and Safety
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
adherence View
utilization View
acute pancreatitis View
Exenatide View
DPP-4 inhibitors View
liraglutide View
GLP-1 receptor agonist View